Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
Technology
E-129-2001
Patent ID
E-129-2001-0-US-03
Country
US
Application Type
ORD
Patent Status
Expired
Patent Number
7355012
Publication Number
US20050118182A1
Application Number
10/490,535
IC
NCI
Date Filed
Date Issued